Showing results (181-190 of 675) with videos related to

Sort By:
Pageof 68
JAMA|March 20, 2008
F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndromeSerena Masciari, Annick D Van den Abbeele, Lisa R Diller, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 26, 2024
Changes in Risk Tolerance for Ovarian Cancer Prevention Strategies during the COVID-19 Pandemic: Results of a Discrete Choice ExperimentBrian L Egleston, Mary B Daly, Kaitlyn Lew, et al.
European Journal of Medical Genetics|October 10, 2021
Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic resultsHuma Q Rana, Diane R Koeller, Alison Schwartz, et al.
Public Health Genomics|March 20, 2020
Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier TestJada G Hamilton, Margaux Genoff Garzon, Ibrahim H Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriersLauren Scheuer, Noah Kauff, Mark Robson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 22, 2019
Correction: Toward automation of germline variant curation in clinical cancer geneticsVignesh Ravichandran, Zarina Shameer, Yelena Kemel, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2024
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndromeMichele Bottosso, Renata L Sandoval, Benjamin Verret, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 22, 2019
Toward automation of germline variant curation in clinical cancer geneticsVignesh Ravichandran, Zarina Shameer, Yelena Kemel, et al.
Clinical Breast Cancer|June 28, 2006
Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessonsHarold J Burstein, Erica Mayer, Ann H Patridge, et al.
Genetics in Medicine Open|December 13, 2024
Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genesNihat B Agaoglu, Brittany L Bychkovsky, Carolyn Horton, et al.
Pageof 68